Advisory Committee Concerned With Injectafer's Mortality Risk

Emily Ethridge

首页> 外文期刊>Washington Drug Letter >Advisory Committee Concerned With Injectafer's Mortality Risk

【24h】

Advisory Committee Concerned With Injectafer's Mortality Risk

机译：注射剂死亡率风险咨询委员会

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Luitpold Pharmaceuticals may qualify or restrict its proposed uses for Injectafer because the FDA's Drug Safety and Risk Management Advisory Committee voted 14-2 with one abstention that available efficacy and safety data do not support a favorable risk-benefit profile.

机译：Luitpold Pharmaceuticals可能会限定或限制其对Injectafer的拟议用途，因为FDA的药物安全和风险管理咨询委员会以14票对2票弃权，认为现有的功效和安全性数据不支持有利的风险收益特征。

著录项

来源
《Washington Drug Letter》 |2008年第6期|p.3|共1页
作者
Emily Ethridge;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类生物科学;
关键词

相似文献

外文文献
中文文献
专利

1. Re: Joint Meeting for Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management Advisory Committee (DSARM AC), September 17, 2014 [J] . Seftel Allen D. The Journal of Urology . 2015,第2期

机译：回复：2014年9月17日，骨，生殖和泌尿科药物咨询委员会（BRUDAC）和药品安全与风险管理咨询委员会（DSARM AC）联席会议
2. The TREAT-NMD Advisory Committee for Therapeutics (TACT): An innovative de-risking model to foster orphan drug development [J] . Wells D., Heslop E., Csimma C., Neuromuscular disorders: NMD . 2015,第Suppla2期

机译：TREAT-NMD治疗学咨询委员会（TACT）：一种创新的降低风险的模型，以促进孤儿药物的开发
3. The TREAT-NMD advisory committee for therapeutics (TACT): an innovative de-risking model to foster orphan drug development [J] . Emma Heslop, Cristina Csimma, Volker Straub, Orphanet journal of rare diseases . 2015,第S1期

机译：TREAT-NMD治疗咨询委员会（TACT）：一种创新的降低风险的模型，以促进孤儿药物的开发
4. In-flight Oxygen: An Increasing Safety Risk- Flight Safety Foundation Corporate Advisory Committee Oxygen Working Group Report [C] . Joan Sullivan Garrett, Ted Mendenhatt, Patty McWhite, 46th Annual Corporate Aviation Safety Seminar (CASS 2001) ― A Safety Odyssey (Humans, Machines and Technology), Apr 24-26, 2001, Orlando, Florida, U.S. . 2001

机译：机上氧气：不断增加的安全风险-飞行安全基金会公司咨询委员会氧气工作组报告
5. Exploring the viability of establishing an advisory committee and determining the role and function and structure of such an advisory committee in addressing issues facing a postsecondary library. [D] . Painter, John Cecil. 1996

机译：探索建立咨询委员会的可行性，并确定该咨询委员会在解决专上图书馆面临的问题方面的作用，职能和结构。
6. The TREAT-NMD advisory committee for therapeutics (TACT): an innovative de-risking model to foster orphan drug development [O] . Emma Heslop, Cristina Csimma, Volker Straub, 2015

机译：TREAT-NMD治疗咨询委员会（TACT）：一种创新的降低风险的模型以促进孤儿药物的开发
7. Guidelines on minimising the risk of transmission of transmissible spongiform encephalopathies in healthcare settings in Ireland / CJD Infection Control Committee on behalf of: Scientific Advisory Committee, NDSC and National CJD Advisory Committee, Department of Health and Children [O] . National Disease Surveillance Centre (NDSC) 2004

机译：爱尔兰/ CJD感染控制委员会代表：科学咨询委员会，NDSC和国家CJD卫生与儿童部咨询委员会，在爱尔兰的医疗机构中将传染性海绵状脑病的传播风险降至最低的准则
8. Morbidity and Mortality Weekly Report, Volume 49, No. RR-14. Recommendations forBlood Lead Screening of Young Children Enrolled in Medicaid: Targeting a Group at High Risk. Advisory Committee on Childhood Lead Poisoning Prevention (ACCLPP) [R] . 2000

机译：发病率和死亡率每周报告，第49卷，第RR-14号。关于招募医疗补助的幼儿血液铅筛查的建议：针对高风险群体。儿童铅中毒预防咨询委员会（aCCLpp）

Advisory Committee Concerned With Injectafer's Mortality Risk

摘要

著录项

相似文献

相关主题

期刊订阅